Ariadne Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$732K Sell
5,696
-862
-13% -$101K 0.32% 83
2026
Q1
$794K Sell
6,558
-14
-0.2% -$1.62K 0.36% 66
2025
Q4
$784K Buy
6,572
+273
+4% +$25.6K 0.32% 68
2025
Q3
$585K Buy
6,299
+835
+15% +$68.8K 0.26% 87
2025
Q2
$452K Buy
5,464
+66
+1% +$5.25K 0.22% 101
2025
Q1
$410K Buy
5,398
+2,526
+88% +$236K 0.21% 104
2024
Q4
$248K Buy
+2,872
New +$296K 0.11% 180

Other funds holding MRK

Ariadne Wealth Management's MRK Position: Q2 2026 in Review

Ariadne Wealth Management reduced its Merck (MRK) stake by 13% in Q2 2026, selling an estimated $101K and leaving 5,696 shares worth $732K. The position accounts for 0.32% of the portfolio, ranked #83.

Ariadne Wealth Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $794K in Q1 2026. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Ariadne Wealth Management held 5,696 shares of Merck worth $732K as of Q2 2026.
  • Ariadne Wealth Management sold 862 Merck shares in Q2 2026, an estimated $101K.
  • Merck made up 0.32% of Ariadne Wealth Management's portfolio in Q2 2026, its #83 holding.
  • Ariadne Wealth Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Ariadne Wealth Management's Merck position peaked at $794K in Q1 2026.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ariadne Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.